Lupin in focus after new drug application for Etanercept

Image
Capital Market
Last Updated : May 09 2018 | 9:04 AM IST

Lupin announced that YL Biologics (YLB) its JV with Yoshindo and Kyowa (Lupin's Subsidiary) in Japan has submitted a New Drug Application (NDA) for Marketing Authorization to the Pharmaceuticals and Medical Devices Agency (PMDA) for a biosimilar of Etanercept to treat indications for moderate to severe Rheumatoid Arthritis (RA) and Juvenile Idiopathic Arthritis. YL Biologics and Kyowa filed the NDA in Japan in March, 2018. The announcement was made after market hours yesterday, 8 May 2018.

Eicher Motors and Jindal Steel & Power will announce January-March 2018 quarterly results today, 9 May 2018.

ABB India's net profit rose 13.9% to Rs 102.49 crore on 16.92% rise in total income to Rs 2552.39 crore in Q1 March 2018 over Q1 March 2017. The announcement was made after market hours yesterday, 8 May 2018.

Blue Dart Express' net profit rose 39.19% to Rs 34.13 crore on 5.84% rise in total income to Rs 722.04 crore in Q4 March 2018 over Q4 March 2017. The announcement was made after market hours yesterday, 8 May 2018.

Automotive Axles' net profit rose 58.22% to Rs 28.29 crore on 30.73% rise in total income to Rs 469.97 crore in Q4 March 2018 over Q4 March 2017. The announcement was made after market hours yesterday, 8 May 2018.

SKF India's net profit rose 23.59% to Rs 71.56 crore on 7.29% rise in total income to Rs 722.45 crore in Q4 March 2018 over Q4 March 2017. The announcement was made after market hours yesterday, 8 May 2018.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 09 2018 | 8:46 AM IST

Next Story